Irene Ghobrial, MD receives SU2C Catalyst grantIrene Ghobrial, MD, co-director of the Center for Prevention of Progression of Blood Cancers, is among the first to receive a research...
Early treatment may prevent progression to multiple myelomaEarly intervention with an immunotherapy-based drug combination may prevent progression of high-risk “smoldering” multiple myeloma to the...
Monoclonal gammopathy of unknown significance (MGUS) & importance of regularly monitoring patientsIrene Ghobrial, MD, of Dana-Farber Cancer Institute, Boston, MA, discusses monoclonal gammopathy of unknown significance (MGUS). There...
How to use social media in clinical trials - reaching out to patients Irene Ghobrial, MD of Dana-Farber Cancer Institute, Boston, MA, discusses ways to use social media in clinical trials. +watch video